India approves PLI scheme for pharmaceuticals
Total incremental sales of Rs.2,94,000 crore and total incremental exports of Rs.1,96,000 crore are estimated during six years from 2022-23 to 2027-28.
Total incremental sales of Rs.2,94,000 crore and total incremental exports of Rs.1,96,000 crore are estimated during six years from 2022-23 to 2027-28.
The pandemic has provided tailwinds in terms of access to rural healthcare and India’s emergence as a vaccine powerhouse
Kushwaha previously served as Chief Digital & Information Officer at Jubilant Ingrevia Limited
The company has projected Rs. 5,630 crores of investment and to provide employment to 6,350 people in three phases over a period of eight years
Enables additional US manufacturing capacity to serve increased demand for pharma/biotech customers
Azelis will strengthen its presence in the domestic market by leveraging portfolio synergies, actively consolidating the business, and creating value for all stakeholders
Enhance strategies to drive sustainability, global Reach and digital transformation for a trillion-dollar future
The company received seven observations in the Form-483
Subscribe To Our Newsletter & Stay Updated